Concepedia
Statistics
Publications
11
Citations
378
H-Index
Active since
1985
Affiliations
National Institutes of Health(Current)
University of California, San Francisco
Winship Cancer Institute
Kyoto University
National Cancer Institute
Yoko Fukuda is an author at National Institutes of Health specializing in medicine, oncology, and pharmacology.
Publications per year
1985–2022
Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis
Mark M. Awad, Giulia C. Leonardi, Sasha Kravets et al. · Lung Cancer · 2019 · 112 citations · Full text
Medicine, Oncology, Pharmacology +15
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials
Dai Chihara, Ruitao Lin, Christopher R. Flowers et al. · The Lancet · 2022 · 65 citations · Full text
Medicine, Oncology, Pharmacology +11
Wilms Tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma
Akihiro Tsuboi, Hiroko Nakajima, Yoko Fukuda et al. · International Journal of Hematology · 2007 · 59 citations
Medicine, Immunology, Oncology +14
Impact of MET inhibitors on survival among patients (pts) with <i>MET</i> exon 14 mutant (<i>MET</i>del14) non-small cell lung cancer (NSCLC).
Mark M. Awad, Giulia C. Leonardi, Sasha Kravets et al. · Journal of Clinical Oncology · 2017 · 32 citations
Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent
Kazuko Horiuchi-Suzuki, A Konno, Mayumi Ueda et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 27 citations
Medicine, Biochemistry, Biology +11
1–5 of 11